An observational study in OSA, Oral Disease and Oropharyngeal Neoplasms, sponsored by Medrobotics Corporation. Completed at 4 sites in 2 countries. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-03-16.
Sponsored by Medrobotics Corporation · Observational
The objectives of this study are to evaluate the performance of the Medrobotics Flex® Robotic System to visualize and access specific anatomical locations along with evaluation of the safety of the device.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
This study's enrollment of 80 is below the median of 204 across 1,683 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Medrobotics Corporation is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects ≥ 22 years of age requiring transoral procedures
Exclusion Criteria:
Subjects ≥ 22 yrs requiring transoral procedures
Access and Visualizaton in Oropharynx, Hypopharynx and Larynx
Ability to access and visualize all the following anatomical locations in the oropharynx, hypopharynx and larynx via transoral only approach. Palatine tonsils, base of tongue, epiglottis, posterior pharyngeal wall, false vocal cords.
Time frame: Intra-Operative
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medrobotics Corporation